/ /

  • linkedin
  • Increase Font
  • Sharebar

    Quarterly Questions is the new gold standard for board certification

    What are Quarterly Questions?


    What is the ABO’s vision for board certification?

    Dr. Bartley explains, “About one-third of our diplomates hold non-time-limited (so-called “lifetime”) certificates. All ABO directors participate in MOC, and we hope that our colleagues who hold non-time-limited certificates will join with their younger colleagues and enroll in the Quarterly Questions program. This would be an admirable demonstration to their patients that they support the idea of life-long learning and accountability.”

    With the successful Quarterly Questions program in place, the future is bright for board certification standards and self-regulation in ophthalmology. The strong leadership in the ABO should be commended for their tireless effort to continue to provide the highest level of professional standards for ophthalmology and being the leading example for all certifying specialty boards in medicine.   

    For more information, visit https://abop.org

    Special thanks to Dr. Bartley and Meghan McGowan from the ABO for their contributions to this article. —Dr. Mali




    Mali, J. Dr. Mali's top 5 stories in ophthalmology in 2017 (so far). Ophthalmology Times.       Sept. 2017. 


    Joshua Mali, MD

    P: 941/923-2020

    Dr. Mali is a board-certified ophthalmologist and vitreoretinal surgeon at The Eye Associates, a private multispecialty ophthalmology practice in Sarasota, FL. 

    Joshua Mali, MD
    Joshua Mali, MD, is a vitreoretinal surgeon at The Eye Associates, a private multispecialty ophthalmology practice in Sarasota, Florida.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results